Quantcast

Latest Prostate cancer Stories

2014-10-14 08:34:17

First Patient Has Begun Treatment Process; Additional Patients Being Assessed; Waiting List Established BETHESDA, Md., Oct.

2014-10-09 08:27:36

ProMark(TM) Validated to Predict Disease Aggressiveness and Empower Informed Treatment Decisions CAMBRIDGE, Mass., Oct.

2014-10-09 08:27:33

SAN ANTONIO, Texas, October 9, 2014 /PRNewswire/ -- GenSpera, Inc.

2014-10-07 23:05:16

With a device necessary for many medical conditions and surgeries, manufacturers of urinary catheters have a safe and stable source of revenue that can withstand the steepest of economic downturns,

2014-10-07 08:28:45

PETACH TIKVA, Israel, Oct. 7, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.

2014-10-03 23:00:25

SonaCare Medical FDA Panel Review for Its Sonablate® 450 Prostate Ablation System CHARLOTTE, NC (PRWEB) October 03, 2014 FRIDAY, OCTOBER 3, 2014

2014-10-02 23:09:36

Colleen’s Dream Foundation, with the help of the Arizona Valley Toyota Dealers Association of Phoenix, AZ, has made a $10,000 gift to the University of Arizona Cancer Center in an effort to

2014-10-02 08:29:14

Study will assess ability of VolitionRx NuQ® to distinguish between aggressive anaplastic prostate cancer and typical castration-resistant prostate cancer (CRPC) NAMUR, Belgium, Oct.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related